Kidney disease in Uganda: a community based study

Robert Kalyesubula, Joaniter I Nankabirwa, Isaac Ssinabulya, Trishul Siddharthan, James Kayima, Jane Nakibuuka, Robert A Salata, Charles Mondo, Moses R Kamya, Donald Hricik, Robert Kalyesubula, Joaniter I Nankabirwa, Isaac Ssinabulya, Trishul Siddharthan, James Kayima, Jane Nakibuuka, Robert A Salata, Charles Mondo, Moses R Kamya, Donald Hricik

Abstract

Background: Chronic kidney disease (CKD) is a major cause of morbidity and mortality in Sub-Saharan Africa (SSA). The majority of studies on CKD in SSA have been conducted among HIV-infected populations and mainly from large health facilities. We determined the prevalence of CKD and its predictors among populations in communities in central Uganda.

Methods: A cross-sectional study was conducted in Wakiso district using multi-stage sampling. Data was collected on age, sex, socio-economic status, history of alcohol intake, diabetes mellitus, hypertension and smoking. Measurement of blood pressure, weight and height to determine body mass index (BMI) and investigations including HIV testing, fasting blood sugar, creatinine and urinalysis were conducted. Logistic regression was used to estimate the strength of the association between variables and the presence of CKD estimated using the Cockcroft Gault formula.

Results: A total of 955 participants aged 18-87 years were enrolled into the study. The median age was 31 years (Interquartile range 24-42) and majority (67%) were female. Up to 21.4% (204/955) had abnormal renal function with CKD stage 1 in 6.2% (59/955), stage 2 in 12.7% (121/955), stage 3 in 2.4% (23/955), CKD stage 4 in 0% and CKD stage 5 in 0.1% (1/995). Female gender OR 1.8 (95% Confidence Interval [CI] 1.2-2.8), age >30 years OR 2.2(95% CI 1.2-3.8) and high social economic status OR 2.1 (95% CI 1.3-3.6) were associated with increased risk of CKD while BMI > 25Kg/m2 was protective against CKD OR 0.1 (95% CI 0.04-0.2). Traditional risk factors such as HIV-infection, diabetes mellitus, smoking and alcohol intake were not found to be significantly associated with CKD.

Conclusion: We found a high prevalence of kidney disease in central Uganda. Interestingly the traditional risk factors associated with CKD previously documented, were not associated with CKD.

Keywords: Chronic kidney disease; Risk factors; Uganda; sub-Saharan Africa.

Figures

Fig. 1
Fig. 1
Map of Uganda Showing urban and rural areas from Wakiso district. This map was adopted and modified by Dr Robert Kalyesubula from wikimedia
Fig. 2
Fig. 2
Prevalence of kidney disease by stage

References

    1. World Health Organization: Global Burden of Disease. Projections of mortality and burden of disease, 2002–2030. 2009. ; .
    1. Stanifer JW, Maro V, Egger J, Karia F, Thielman N, Turner EL, Shimbi D, Kilaweh H, Matemu O, Patel UD. The epidemiology of chronic kidney disease in Northern Tanzania: a population-based survey. PloS one. 2015;10(4):e0124506. doi: 10.1371/journal.pone.0124506.
    1. El Nahas M. The global challenge of chronic kidney disease. Kidney Int. 2005;68(6):2918–29. doi: 10.1111/j.1523-1755.2005.00774.x.
    1. Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol. 2009;5(10):591–8. doi: 10.1038/nrneph.2009.141.
    1. Peters PJ, Moore DM, Mermin J, Brooks JT, Downing R, Were W, Kigozi A, Buchacz K, Weidle PJ. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 2008;74(7):925–9. doi: 10.1038/ki.2008.305.
    1. Stohr W, Walker AS, Munderi P, Tugume S, Gilks CF, Darbyshire JH, Hakim J. Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae. Antivir Ther. 2008;13(6):761–70.
    1. Lucas GM, Clarke W, Kagaayi J, Atta MG, Fine DM, Laeyendecker O, Serwadda D, Chen M, Wawer MJ, Gray RH. Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr. 2010;55(4):491–4. doi: 10.1097/QAI.0b013e3181e8d5a8.
    1. Mateen FJ, Kanters S, Kalyesubula R, Mukasa B, Kawuma E, Kengne AP, Mills EJ. Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens. 2013;31(7):1372–8. doi: 10.1097/HJH.0b013e328360de1c.
    1. Kalyesubula R, Lunyera J, Makanga G, Kirenga B, Amukele TK. A 4-year survey of the spectrum of renal disease at a National Referral Hospital Outpatient Clinic in Uganda. Kidney Int. 2015;87(3):663. doi: 10.1038/ki.2014.411.
    1. Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174–81. doi: 10.1016/S2214-109X(14)70002-6.
    1. Davids MR, Eastwood JB, Selwood NH, Arogundade FA, Ashuntantang G, Benghanem Gharbi M, Jarraya F, MacPhee IA, McCulloch M, Plange-Rhule J, et al. A renal registry for Africa: first steps. Clin Kidney J. 2016;9(1):162–7. doi: 10.1093/ckj/sfv122.
    1. Babua C, Kalyesubula R, Okello E, Kakande B, Sebatta E, Mungoma M, Mondo C. Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study. BMC Nephrol. 2015;16:126. doi: 10.1186/s12882-015-0128-z.
    1. Bastos MG, Kirsztajn GM. Chronic kidney disease: importance of early diagnosis, immediate referral and structured interdisciplinary approach to improve outcomes in patients not yet on dialysis. J Bras Nefrol. 2011;33(1):93–108. doi: 10.1590/S0101-28002011000100013.
    1. Jiang Z, Zhang X, Yang L, Li Z, Qin W. Effect of restricted protein diet supplemented with keto analogues in chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol. 2016;48(3):409–18. doi: 10.1007/s11255-015-1170-2.
    1. Nakibuuka J, Sajatovic M, Nankabirwa J, Furlan AJ, Kayima J, Ddumba E, Katabira E, Byakika-Tusiime J. Stroke-risk factors differ between rural and urban communities: population survey in Central Uganda. Neuroepidemiology. 2015;44(3):156–65. doi: 10.1159/000381453.
    1. Kayima J, Nankabirwa J, Sinabulya I, Nakibuuka J, Zhu X, Rahman M, Longenecker CT, Katamba A, Mayanja-Kizza H, Kamya MR. Determinants of hypertension in a young adult Ugandan population in epidemiological transition-the MEPI-CVD survey. BMC Public Health. 2015;15:830. doi: 10.1186/s12889-015-2146-y.
    1. Carroll MF, Temte JL. Proteinuria in adults: a diagnostic approach. Am Fam Physician. 2000;62(6):1333–40.
    1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
    1. Mula-Abed WA, Al Rasadi K, Al-Riyami D. Estimated Glomerular Filtration Rate (eGFR): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice. Oman Med J. 2012;27(2):108–13. doi: 10.5001/omj.2012.23.
    1. UBOS. 2015. Available at . Accessed 20th July 2016.
    1. Kalyesubula Odiit A, Wekesa C, Katali E, Sekasanvu E, Kotanko P, Carter M. A time to improve kidney disease care and awareness in Uganda. Dialysis Times. 2012;19(2):1–4.
    1. Abu-Aisha H, Elamin S. Peritoneal dialysis in Africa. Perit Dial Int. 2010;30(1):23–8. doi: 10.3747/pdi.2008.00226.
    1. Luyckx VA, Naicker S, McKee M. Equity and economics of kidney disease in sub-Saharan Africa. Lancet. 2013;382(9887):103–4. doi: 10.1016/S0140-6736(13)60817-X.
    1. UBOS . Uganda National Household Survey 2012/2013. UBOS: Kampala Uganda; 2014.
    1. Byrne C, Nedelman J, Luke RG. Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis. 1994;23(1):16–22. doi: 10.1016/S0272-6386(12)80806-7.
    1. Wyatt CM, Shi Q, Novak JE, Hoover DR, Szczech L, Mugabo JS, Binagwaho A, Cohen M, Mutimura E, Anastos K. Prevalence of kidney disease in HIV-infected and uninfected Rwandan women. PloS one. 2011;6(3):e18352. doi: 10.1371/journal.pone.0018352.
    1. Kaze FF, Halle MP, Mopa HT, Ashuntantang G, Fouda H, Ngogang J, Kengne AP. Prevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study. BMC Nephrol. 2015;16:96. doi: 10.1186/s12882-015-0102-9.
    1. Inal BB, Oguz O, Emre T, Usta M, Inal H, Altunoglu E, Topkaya C. Evaluation of MDRD, Cockcroft-Gault, and CKD-EPI formulas in the estimated glomerular filtration rate. Clin Lab. 2014;60(10):1685–94.
    1. Yildiz G, Magden K, Abdulkerim Y, Ozcicek F, Hur E, Candan F. Glomerular filtration rate: which method should we measure in daily clinical practice? Minerva Med. 2013;104(6):613–23.
    1. Delanaye P, Mariat C, Maillard N, Krzesinski JM, Cavalier E. Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations? Clin J Am Soc Nephrol. 2011;6(4):906–12. doi: 10.2215/CJN.10931210.
    1. Eastwood JB, Kerry SM, Plange-Rhule J, Micah FB, Antwi S, Boa FG, Banerjee D, Emmett L, Miller MA, Cappuccio FP. Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations. Nephrol Dial Transplant. 2010;25(7):2178–87. doi: 10.1093/ndt/gfp765.
    1. Bello AK, Peters J, Rigby J, Rahman AA, El Nahas M. Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. Clin J AmSoc Nephrol. 2008;3(5):1316–23. doi: 10.2215/CJN.00680208.
    1. Stanifer JW, Egger JR, Turner EL, Thielman N, Patel UD. Neighborhood clustering of non-communicable diseases: results from a community-based study in Northern Tanzania. BMC Public Health. 2016;16:226. doi: 10.1186/s12889-016-2912-5.
    1. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117. doi: 10.1186/1471-2458-8-117.
    1. Hecking M, Bieber BA, Ethier J, Kautzky-Willer A, Sunder-Plassmann G, Saemann MD, Ramirez SP, Gillespie BW, Pisoni RL, Robinson BM, et al. Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS) PLoS Med. 2014;11(10):e1001750. doi: 10.1371/journal.pmed.1001750.
    1. Bahendeka S, Wesonga R, Mutungi G, Muwonge J, Neema S, Guwatudde D. Prevalence and correlates of diabetes mellitus in Uganda: a population-based national survey. Trop Med Int Health. 2016;21(3):405–16. doi: 10.1111/tmi.12663.
    1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72. doi: 10.1016/S0140-6736(13)60687-X.
    1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82. doi: 10.1016/S0140-6736(14)61601-9.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel